期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

间充质干细胞在骨髓造血重建中作用的研究进展 被引量：4

下载PDF
导出
摘要 间充质干细胞（mesenchymal stem cell,MSC）是机体内具有自我更新和多向分化潜能的非造血类干细胞,具有支持造血、免疫抑制、促进微血管形成等功能。MSC与造血干细胞（hematopoietic stem cell,HSC）共移植可促进移植后造血重建,机体造血功能恢复加快。但是MSC促进造血重建的机制仍有争议，对MSC作用机制的探讨，将有助于实现MSC在临床上的更广泛应用。
作者 代凯 陈洁平
机构地区 第三军医大学西南医院血液病中心
出处 《重庆医学》 CAS 北大核心 2015年第11期1553-1555,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(NSFC 81270605) 重庆市科委攻关资助项目(CSTC 2008BA5001)
关键词 间充质干细胞 造血干细胞 移植后造血重建
分类号 R329.2 [医药卫生—人体解剖和组织胚胎学]
  • 相关文献

参考文献28

  • 1Sokolov M, Neumann R. Lessons learned about human stem cell responses to ionizing radiation exposures:a long road still ahead of us[J]. Int J Mol Sci,2013,14(8): 15695-15723.
  • 2Ding L, Zhu H, Yang Y, et al. Functional mesenchymal stem cells remain present in the bone marrow microenvi- ronment of leukemia patients post allogeneic hematopoiet- ic stem cell transplantation[J]. Leuk Lymphoma, 2014,55 (7) : 1635-1644.
  • 3Kim EJ,Kim N,Cho SG. The potential use of mesenchy- mal stem cells in hematopoietic stem cell transplantation [J]. Exp Mol Med,2013,45(1) :e2.
  • 4Law S,Chaudhuri S. Mesenchymal stem cell and regener- ative medicine: regeneration versus immunomodu]atory challenges[J]. Am J Stem Cells, 2013,2 ( 1 ) : 22-38.
  • 5Mohammadian M, Shamsasen)an K. Mesenchymal stem cells : new aspect in cell-based regenerative therapy[J]. Adv Pharm Bull, 201 S ,3(2) :433-437.
  • 6Wu KH, Tsai C, Wu HP, et al. Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells:enhance hematopoiesis after cord blood transplanta- tion [J]. Cell Transplant,2013,22(11) :2041-2051.
  • 7Bernardo ME, Cometa AM, Locatelli F. Mesenchymal stromal cells : a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? [J]. Bone Marrow Transplant, 2012,47(3) : 323-329.
  • 8Fouillard L, Francois S, Bouchet S, et al. Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution [J]. Curt Pharm Biotechnol, 2013,14 (9) : 842-848.
  • 9Mohammadian M, Shamsasenjan K. Mesenchymal stem cells:new aspect in cell-based regenerative therapy[J]. Adv Pharm Bull,2013,3(2) :433-438.
  • 10Walenda T, Bokermann G, Ventura-Ferreira MS, et al. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells[J]. Exp Hematol,2011,39(6) :617-628.

二级参考文献20

  • 1Ye, Zhou,Wang, Yan,Xie, Hai-Yang,Zheng, Shu-Sen.Immunosuppressive effects of rat mesenchymal stem cells:involvement of CD4^+ CD25^+ regulatory T cells[J].Hepatobiliary & Pancreatic Diseases International,2008,7(6):608-614. 被引量：15
  • 2王景昌,白海,吴涛,路继红,欧剑峰.人骨髓间充质干细胞对异体T淋巴细胞增殖的影响及机制研究[J].实用医学杂志,2006,22(5):494-496. 被引量：2
  • 3Muguruma Y, Yahata T, Miyatake H, el al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood, 2006,107 : 1878-1887.
  • 4Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood ,2006,107:367-372.
  • 5Bensidhoum M, Chapel A, Francois S, et al. Homing of in vitro expanded Stro-1- or Stro-1 + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood,2004,103:3313-3319.
  • 6Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005,105 : 1815- 1822.
  • 7Moadsiri A,Polchert D,Genrich K, et al. Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts. Surgery,2006,140: 315-321.
  • 8Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant,2005,11:389-398.
  • 9Ball LM, Bemardo ME, Roelofs H, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 2007,110: 2764- 2767.
  • 10Ketterer N, Salles G, Raba M, et al. High CD34 + cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood,1998,91:3148-3155.

共引文献25

同被引文献17

引证文献4

二级引证文献2

重庆医学
2015年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部